chrisvoncsefalvay/vaers-outcomes huggingface dataset:
got shingrix, small area on my forearm that blistered, would have gotten a lot worse without the shot / suspected vaccination failure; tingling nerve type pain; tingling; shut my arm DOWN; small area on my forearm that blistered; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included shingles (Family History) (husband had shingles on his ankle to knee and some on his thigh after Christmas last year).   On an unknown date, the patient received Shingrix. In January 2021, less than 9 months after receiving Shingrix, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles, nerve pain, tingling and arm discomfort. On an unknown date, the outcome of the vaccination failure, nerve pain and arm discomfort were unknown and the outcome of the shingles was recovered/resolved and the outcome of the tingling was not recovered/not resolved.   It was unknown if the reporter considered the vaccination failure, shingles, nerve pain, tingling and arm discomfort to be related to Shingrix.  Additional case details were reported as follows: The reporter was patient itself. The age at vaccination was not reported. The patient got shingrix a couple of years ago before COVID showed up. The patient's husband had shingles on his ankle to knee and some on his thigh after Christmas last year. In January, patient had a small area on her forearm that blistered a bit. It lasted about 3 to 4 weeks but did not grow or hurt. The only thing the patient still had is a tingling nerve type pain that shoots down that arm from my shoulder. It happens sometimes 4 times a day and sometimes once a week. This case was considered as suspected vaccination failure, as details regarding completion of primary vaccination schedule and laboratory test confirmation were unknown at the time of reporting. The follow up was not required.
Pfizer-BioNTech COVID-19 Vaccine EUA I had normal pain at the injection site  after the shot, which went away after a  couple of days. A few days later a different part of that upper arm and shoulder became painful to move certain ways. I saw my primary care physician and he said the shot must have nicked the bursa under the muscle. He diagnosed bursitis and prescribed diclofenac gel.
Patchy hair loss, consistent with Alopecia Areata, beginning in April 2022.
This case was reported by a physician via call center representative and described the occurrence of vaccine administered at inappropriate site in a 18-year-old female patient who received BEXSERO (batch number 158401, expiry date unknown). On 13th April 2017, the patient received BEXSERO. On 13th April 2017, unknown after receiving BEXSERO, the patient experienced vaccine administered at inappropriate site. On an unknown date, the outcome of the vaccine administered at inappropriate site was unknown. Additional details were reported as follows: The patient received a dose of BEXSERO inadvertently into the joint capsule of the left shoulder, which led to vaccine administered at inappropriate site. Follow up information was received from a physician on 25th May 2017: The patient's demographic details were updated. The patient received 1st dose of BEXSERO 0.5 ml intramuscularly. In 2017, less than a year after vaccination with BEXSERO, the patient experienced bursitis. At the time of reporting, bursitis was completely resolved. It was unknown if the reporter considered the bursitis to be related to BEXSERO. The VAERS details were updated.
Pt. presented to UC with change in mental status; arrived from extended care facility; discharged home on 05/20/21 to hospice care. Pt.'s son called to cancel subsequent appointments because  pt. passed away on 05/27/21.
Patient received COVID19 Pfizer vaccine at 3:17pm. Patient was sitting in chair. Patient developed nausea, vomiting and itchiness. On exam, no hives or lip swelling.  Administered Benadryl 50mg IM on right arm at 3:24pm. At 3:27pm BP 127/23, HR 65, O2 sat 976. Patient continued to have vomiting. Vital signs were taken again and machine was not able to record blood pressure and patient was actively vomiting. Patient developed abdominal cramping and shortness of breath. I called for nurse to get stretcher, and security and transport was notified. I administered Epipen 0.3mg IM at 3:32pm. Oxygen by Nasal cannula started. RRT called. FS was 106. Patient transferred to stretcher and transferred to ER at 3:42. Patient was not in respiratory distress.
dose administered from a carton of vials some of which did not thaw as expected; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT STORAGE ERROR (dose administered from a carton of vials some of which did not thaw as expected) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 019F21A) for COVID-19 vaccination.     Concurrent medical conditions included COPD since 14-Feb-2014, Chronic pain since 11-Oct-2019, Anxiety on 09-Dec-2013, Hypertension, Allergy (Bee) and Pollen allergy. Concomitant products included FERROUS GLUCONATE (FERGON) from 11-Mar-2016 to an unknown date for Anemia, ALPRAZOLAM (XANAX) from 09-Dec-2013 to an unknown date for Anxiety, OXYCODONE from 28-Nov-2010 to an unknown date for Chronic pain, METOPROLOL from 18-Jul-2014 to an unknown date for Hypertension, ERGOCALCIFEROL (DRISDOL) from 11-Mar-2016 to an unknown date for Vitamin D deficiency.    On 24-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT STORAGE ERROR (dose administered from a carton of vials some of which did not thaw as expected). At the time of the report, PRODUCT STORAGE ERROR (dose administered from a carton of vials some of which did not thaw as expected) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 30-Sep-2021: Follow up received on 30-Sep-2021. Patient's information (age, race, demographics), medical history and concomitant medications were updated. New reporter added.
First day, Saturday evening:  headache and feeling quite tired by 8:00pm.  Sunday evening, Jan 24:  A strange short period of sneezing with runny nose for about one hour and also left arm shot site was sore and tender. Monday, January 25 lump at shot site that was tender; Tuesday, January 26, lump was gone; Wednesday, January 27 felt chilled to the bone and could not get warm.  Thereafter no side affects.
I broke out whit little bumps; I am itchy all over; Last night it was so bad it was burning; This is a spontaneous report from a contactable consumer (patient). A 65-year-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; Formulation: Solution for injection) via an unspecified route of administration as single dose for covid-19 immunisation. Medical history included covid-19, patient had Covid back in December at Christmas time. Concomitant medication was not reported. On an unspecified date the patient experienced broke out with little bumps and experienced itchy all over, and last night it was so bad it was burning. Second dose was scheduled on 15, patient stated it is not contraindicated to receive the second dose based on his reaction. Therapeutic measures were taken by taking Benadryl which helping a little bit. The outcome of the events was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
he couldn't move his shoulders or his arms; alarming reaction of pleurisy/I believed it was pleurisy there's inflammation of the lining of the lungs it lasted about a day; hard time breathing; Had a real severe sharp pain about few inches below his clavicle; This is a spontaneous report from a contactable consumer. A 21-years-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EW0172; Expiration Date: 31Aug2021), dose 1 via an unspecified route of administration, administered in arm Left on 28May2021 17:00 (Age At vaccination 21years) as 1st dose, single dose for covid-19 immunisation. Medical history included seasonal allergy (Verbatim: Pollen allergy), allergy to animal (Verbatim: Allergic to cats), Allergy to some nuts (Verbatim: Allergies to some nuts, allergy to animal (Verbatim: Allergies to crustaceans) He's not taking any of the drugs for it. The patient's concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 10Jun2021 the patient experienced about 20 minutes he couldn't move his shoulders or his arms, alarming reaction of pleurisy/he believed it was pleurisy there's inflammation of the lining of the lungs it lasted about a day, hard time breathing, had a real severe sharp pain about few inches below his clavicle. After 20 minutes he was able to go to sleep but then it woke him up in the middle of the night and but after a day it was pretty much gone. Reporter is wondering if he should receive the second vaccine which is due on the Friday 18Jun2021. Reporter has a friend who had the exact same thing happen after the moderna shot. She went to the urgent care and was given ibuprofen. She wanted to know if her son really needs that second shot, he does not want him to get the second dose, if her son was in the age group that is immune after the second dose or not. Reporter requested to speak to team studying myocardia because son's health care. reporter don't think he needs the second shot for immunity because of his age and his lung linings something being inflamed his organs that scares him about his heart. He got the Pfizer COVID-19 Vaccine about 2 weeks ago. reporter want to say 5 foot 9 and he's probably 160 maybe a 160 pounds I think so yeah it's either 155 or 160 he is not sure. he was thinking of taking him to get an antibody test, just to find out that he can get the second shot. Patient received treatment of Advil for Had a real severe sharp pain about few inches below his clavicle, reporter think he just took one pill. The patient underwent lab tests and procedures which included weigh was he's probably 160, weight was it's either 155 or 160 on an unspecified date, weight was maybe a 160 pounds lbs on. Onan unspecified date in 2021, the patient had recovered from the events.
Information has been received from a physician and a practice manager referring to a patient of unknown age and gender. On 28-DEC-2015 the patient was vaccinated with an improperly stored dose of GARDASIL (lot # K016966, expiration date 10-MAY-2017, dose and route not reported). No adverse effect were reported. This specified lot number vaccine was exposed to temperature excursion. The total cumulative excursion time was 48 hours, the lowest recorded temperature was 34 Fahrenheit degree and the type of excursion was refrigerator (R). The storage criteria was R. This is one of several reports received from the same source. Additional information has been requested.
right arm where shot was given began to be sore and then itch and when I looked at it there was a rash a few inches long and oval in shape.  It is the 2nd day of the rash and it is the same in size and redness but not as itchy and some soreness.
Right arm and upper body became numb.  Redness and bruising appeared around injection spot with clear liquid forming around skin
Child received 7 vaccinations in arms. Broke out w/red splotches then hives on chest, back, arms & forehead. Vitals stable. No resp problems noted. BENADRYL 12.5 mg PO given. Hives were gone 30-45 minutes. Recovered - no complications.
Mild -> moderate local reaction to (RT) thigh, app. 2cm x 1cm area with erythema & firm induration. 2mo imm. given on 2/21/11, s/s appeared 2/23/11 Tx - apply warm/moist compresses x 10-15 min, PRN.
It began with a metallic taste in the back of the throat about 15 minutes after the shot was administered (February 16).  In an hour my tongue and lips were tingling and my throat was swelling slightly.  I called the pharmacy and was advised to take Benadryl.   I took doses at 4:00 and 10:00 PM that day and at 11:00  AM the next day (February 17).  By 3:00 PM I could feel tingling and swelling in my throat, lips and tongue.  I called my primary care doctor.  She told me to take more Benadryl and go to the ER.   She told me not to get the second vaccine.   I went to the ER and they checked me out, observed me and gave me a steroid shot.  The ER doctor also told me not to get the second shot, that the risks would outweigh the benefits.   He gave me a prescription for steroids and an epi-pen.   I still felt some swelling in my throat for about a week.   Since then I?ve been fine.
The next day of vaccine on 1/10/2021 in the afternoon I started feeling very fatigue & taquicardia my heart rate was in the 90s. On 1/11/2021 I couldn't do anything I stayed home I still had fatigue but I also had a server headache. The fatigue went away by 1/12/2021 but I still had a headache it felt like a pressure headache & that went away until 1/16/2021.
She was a healthcare worker.  It was reported to me by her immediate supervisor that she tested positive for COVID-19 the day after her first vaccination.  She became symptomatic around January 21, 2021. She was scheduled to return to work on January 29, 2021 but did not come in. She died on February 2, 2021.
Began having side effects roughly 8 hours after shot. Felt like severe flu and lasted for 4-5 days. The majority of side effects went away. However as of this writing it has been 19 days since the vaccine and I still have a cough, shortness of breath, severe brain fog, and weakness in limbs. The weakness in limbs is in my quads, hamstrings, and hands. In addition to feeling weak my legs feel very wobbly.
24 hrs Nausea, Headache, Photophobia, Fever, Sweating, Arm swelling, redness and axillary L node enlargement.
- Got severe headache after 2 - 3 week of taking the vaccine. - The headache reduce overtime, but one morning wake up with severe pain in the neck. Can not move the neck because the pain will transfer to the head.  - The neck pain continues for 2 weeks and gradually reduced after taking acetaminophen 500mg. However, a minor neck pain still remains.
Patient was given a 3rd dose of Varicella vaccine mistakenly by his pediatricians office. He was only supposed to get 2 doses ever. I asked the doctor to report it to VAERS and they wouldn't do it.  I was unable to find very much information online about getting too many doses of a vaccine. I did find a VAERS report that analyzed extra vaccine doses so I am reporting this mistake.
Went to hospital on 6/5/21 with dyspnea and was diagnosed with COVID-19. Placed on supplemental O2, then BiPAP. Intubation   attempted 6/8 but could not so used bag-valve mask x 3-4 hrs until EMS arrived to intubate her and transport her to our hospital. Received dexamethasone 6mg BID x 2 days then daily x 8 days; remdesivir x 5 days, tocilizumab 800mg x 1 on 6/8. Also received ceftriaxone + doxycycline in case of CAP for 5 days. Lab values at our hospital (starting 6/8) were: WBC 17.7 -- > 13.6 -- > 11.3 -- > 10.3 -- > 8.9 -- > 9.8. CRP 15.3 -- > 8.16 -- > 4.08 mg/dL Procalcitonin 2.26 -- > 1.26 -- > 0.64 d-dimer 4567 -- > 1586 -- > 2235 fibrinogen 543 -- > 496 -- > 387 LFTs and SCr within normal limits during stay Other meds include: cisatracurium infusion 6/8 -- > 6/12 midazolam infusion 6/8 -- > 6/12 norepinephrine infusion 6/8 -- > 6/9 propofol infusion 6/8 -- > 6/15 Remained on ventilator 6/8 until 6/15 when she was extubated for comfort care measures. As of 6/16/21 when this report is being submitted, patient is still alive however is on hospice. Total duration of hospitalization at our facility is 9 days so far; was admitted to other hospital from 6/5 through 6/8 prior to transfer to us.
This spontaneous report was received from a registered nurse and refers to a 60 year old female patient. The patient's concurrent conditions, medical history and concomitant therapies were not reported. The stock of vaccine was received on 22-AUG-2016. On 30-SEP-2016, the patient was vaccinated with an improperly stored ZOSTAVAX lot # M020921 with expiration date of 18-JUL-2017 (dose, route and frequency were not reported) for prophylaxis. It was stated that the vaccine underwent a temperature excursion of 6 degrees Fahrenheit to 14 degrees Fahrenheit for 3 days. It was reported that there was no need to repeat vaccine.  This is one of the several reports received from the same reporter.; Sender's Comments:  US-009507513-1705USA014052:
fat necrosis near injection site left; several large lipomas; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE NECROSIS (fat necrosis near injection site left) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) unknown. On an unknown date, the patient experienced VACCINATION SITE NECROSIS (fat necrosis near injection site left) (seriousness criterion medically significant) and LIPOMA (several large lipomas). At the time of the report, VACCINATION SITE NECROSIS (fat necrosis near injection site left) and LIPOMA (several large lipomas) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product was not provided. Treatment medication was not reported.  Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Approx 8-10 min after vaccines administered client c/o nausea and dizziness, body became stiff with "seizure like" activity, was unresponsive but quickly became responsive, c/o "metal like" taste and "felt like she had just awakened from a nap." EMS was called and client was transported to the ED.
Information has been received from a physician concerning a 17-week-old female who on 06-NOV-2007 was vaccinated with the first dose of RotaTeq. The patient was seen in the physician's office. Additional information has been requested.
I experienced greater fatigue and a slight cough at first.  Tested on 4/18/2023 with an At Home COVID-19 test, positive.  4/19 doctors office referred to an Urgent Care that specialized in COVID-19 cases.  The Physician?s assistant there had a blood test before proscribing Paxlovid and to treat symptomatically.  Barely noticed any symptoms and by the end of the 4th day taking Paxlovid, symptoms were not noticeable.
On 2/25/00, Mom took child to clinic. The child had developed pustules on 2/24/00 in the area where the immunizations were given. Currently there are two red circles within the smaller one, no pustules.
Night sweats; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of NIGHT SWEATS (Night sweats) and FATIGUE (Fatigue) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Jun-2021, the patient experienced NIGHT SWEATS (Night sweats) and FATIGUE (Fatigue). On 05-Jun-2021, NIGHT SWEATS (Night sweats) and FATIGUE (Fatigue) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       Concomitant product details was not provided by the reporter.  Treatment information was not provided.   This case was linked to MOD-2021-245689 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 12-Jul-2021: Additional information received on 12-JUL-2021 included no new information. On 07-Sep-2021: Follow-up Information received contains No New Information
Since the vaccination, has the patient been tested for COVID-19?:Yes/covid test result=Positive; Since the vaccination, has the patient been tested for COVID-19?:Yes/covid test result=Positive; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient.  A 19 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 17May2021 14:00 (Lot number: EW0179) at the age of 19 years as dose 2, single and administered in arm left (Lot number: EW0179) as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 26Jan2022, outcome "unknown" and all described as "Since the vaccination, has the patient been tested for COVID-19?:Yes/covid test result=Positive". The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (26Jan2022) positive, notes: Nasal Swab. Therapeutic measures were not taken as a result of covid-19.  Clinical Information: The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not have any known allergies. The reporter stating events as non serious. The patient was not prolonged hospitalization due to events. Since the vaccination, has the patient been tested for COVID-19 was yes reported. The complaint for lack of effect of the PFIZER-BIONTECH COVID19 VACCINE lot EW0179 was investigated. The investigation included a review of manufacturing and packaging batch records, deviation investigations, analytical release test results, and an analysis of complaint history for the reported lot. The final scope was determined to be the reported finished goods lot EW0179, fill lot EP8730, and the bulk formulated drug product lot EP8611. A complaint sample was not returned. No related quality issues were identified during the investigation. There is no impact on product quality. No root cause or CAPA were identified as the complaint was not confirmed. All release testing performed prior to the release of the reported batch was within specifications.This is a spontaneous follow-up report received in response to the mail trail sent regarding the translation of Initial report. This report included that: Reaction/event as reported by primary source: My card's ink got faded and vaccination data are illegible.  No follow-up attempts are possible. No further information is expected.
Rash on injection arm started 7 days after injection. Rash fully cleared up after 14 days from onset of rash, which was 21 days after injection.
pt recv vax 13AUG97 & w/in 3-4 hr post vax pt devel approx ten vesicles, some of which were fluid filled & a mild fever of 99.2;